Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Growth Metrics

Mitesco (MITI) Asset Writedowns and Impairment (2020 - 2025)

Mitesco's Asset Writedowns and Impairment history spans 3 years, with the latest figure at -$17651.0 for Q4 2025.

Quarterly results put Asset Writedowns and Impairment at -$17651.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $8700.0 (changed N/A YoY), and the annual figure for FY2025 was $8700.0, changed.
Asset Writedowns and Impairment for Q4 2025 was -$17651.0 at Mitesco, down from $6976.0 in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $83810.0 in Q1 2023 to a low of -$17651.0 in Q4 2025.